Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-25 @ 7:08 PM
NCT ID:
NCT02425904
Group ID:
EG000
Title:
Recurrent or Refractory Langerhans Cell Histiocytosis (LCH) + Clofarabine
Description:
Participants with recurrent or refractory LCH defined as with multi-focal or multi-system disease who have recurred (or have refractory disease) after at least one prior systemic chemotherapy regimen.
Patient will receive Clofarabine administered via IV on days 1-5, 25 mg/m2/day per cycle for 2 cycles. At the end of cycle 2 if no disease progression, will continue with same dose for maintenance treatment for 4 additional cycles.
Clofarabine: second-generation purine nucleoside analog
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
20
Other Number Affected:
20
Other Number At Risk:
20
Study:
NCT02425904
Results Section:
NCT02425904
Adverse Events Module:
NCT02425904